Zoetis Inc. (ZTS)
Zoetis: The King Of Animal Health On Sale
Zoetis Inc. (ZTS) is a wide-moat animal health leader, rated BUY due to strong fundamentals and undervaluation despite industry-leading profitability. Zoetis trades at a forward P/E of 17.28x, below both S&P 500 and weaker rival Elanco, with a target price of $150 implying 25% upside. Risks center on Librela/Solensia safety concerns, with FDA post-marketing study results in 1H 2026 being a critical near-term catalyst.
Zoetis (ZTS) Loses 8.1% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Zoetis (ZTS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Dynamic Technology Lab Private Ltd Sells 9,939 Shares of Zoetis Inc. $ZTS
Dynamic Technology Lab Private Ltd lessened its stake in Zoetis Inc. (NYSE: ZTS) by 85.3% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,711 shares of the company's stock after selling 9,939 shares during the quarter. Dynamic
Zoetis Inc. (ZTS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Zoetis Inc. (ZTS) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Zoetis Inc. (ZTS) Presents at Leerink Global Healthcare Conference 2026 Transcript
Zoetis Inc. (ZTS) Presents at Leerink Global Healthcare Conference 2026 Transcript
Here's Why Zoetis (ZTS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zoetis Inc. (ZTS) Presents at BofA Securities Animal Health Summit Transcript
Zoetis Inc. (ZTS) Presents at BofA Securities Animal Health Summit Transcript
Alliance Wealth Advisors LLC UT Lowers Stock Position in Zoetis Inc. $ZTS
Alliance Wealth Advisors LLC UT trimmed its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 21.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,188 shares of the company's stock after selling 4,430 shares during the
Why Zoetis (ZTS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Zoetis Inc. (ZTS) Q4 2025 Earnings Call Transcript
Zoetis Stock Gains After Q4 Earnings & Revenues Beat Estimates
ZTS stock rises after Q4 earnings and revenues top estimates, as strong international growth and upbeat 2026 guidance offset U.S. softness.
Zoetis (ZTS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
While the top- and bottom-line numbers for Zoetis (ZTS) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
